Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161250 · ClinicalTrials.gov registry record · NA
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02161250: Completed NA study, sponsored by Purdue University.
NCT02161250 is a NA study that has completed, run by Purdue University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02161250, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Hypothesis: A beverage with a resistant starch will blunt and sustain the post-prandial rise in blood glucose and insulin concentrations compared to beverage with maltodextrin (an easily digested carbohydrate).
Primary Outcome
effects of resistant starch consumption of area under the curve of blood serum glucose, insulin, and hydrogen breath testing.
Interventions
- DIETARY_SUPPLEMENT Resistant Starch
- DIETARY_SUPPLEMENT Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT02161250 record still lists
NCT02161250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Resistant Starch is the first listed.
NCT02161250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02161250 about?
NCT02161250 is a clinical study titled "Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses". Hypothesis: A beverage with a resistant starch will blunt and sustain the post-prandial rise in blood glucose and insulin concentrations compared to beverage with maltodextrin (an easily digested carbohydrate).
What is the current status of trial NCT02161250?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02161250?
The interventions under investigation include: Resistant Starch (DIETARY_SUPPLEMENT), Control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02161250?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02161250's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia